Jakob Eberhard

affiliated with the university
More filtering options
  1. 2021
  2. Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations

    Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Ploen, Jakob Eberhard, Jan Lindebjerg & Lars Henrik Jensen, 2021 Jul 1, In: International Journal of Cancer. 149, 1, p. 119-126 8 p.

    Research output: Contribution to journalArticle

  3. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer

    Sofie Olsson Hau, Sara Wahlin, Sophie Cervin, Vilgot Falk, Björn Nodin, Jacob Elebro, Jakob Eberhard, Bruce Moran, William M. Gallagher, Emelie Karnevi & Karin Jirström, 2021, (Accepted/In press) In: Journal of Pathology: Clinical Research.

    Research output: Contribution to journalArticle

  4. 2020
  5. 2019
  6. Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment

    K. Weibring, C. Nord, O. Ståhl, J. Eberhard, K. Sandberg, H. Johansson, S. Arver, A. Giwercman & G. Cohn-Cedermark, 2019, In: Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 604-611 8 p.

    Research output: Contribution to journalArticle

  7. 2018
  8. A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes

    SOFIE OLSSON HAU, Emelie Karnevi, Sebastian Lundgren, Bo Li, Seodhna Lynch, Jacob Elebro, Margareta Heby, Björn Nodin, Jakob Eberhard, Mathias Uhlen, Bruce Moran, William M Gallagher & Karin Jirström, 2018 Feb 1, p. 305-305. 1 p.

    Research output: Contribution to conferencePoster

  9. High risk of hypogonadism in young male cancer survivors

    S. Isaksson, K. Bogefors, O. Ståhl, J. Eberhard, Y. L. Giwercman, I. Leijonhufvud, K. Link, I. Øra, P. Romerius, J. Bobjer & A. Giwercman, 2018, In: Clinical Endocrinology. 88, 3, p. 432-441

    Research output: Contribution to journalArticle

  10. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification

    Emelie Karnevi, Liv Ben Dror, Adil Mardinoglu, Jacob Elebro, Margareta Heby, Sven Erik Olofsson, Björn Nodin, Jakob Eberhard, William Gallagher, Mathias Uhlén & Karin Jirström, 2018, In: Oncotarget. 9, 5, p. 6188-6200 13 p.

    Research output: Contribution to journalArticle

  11. 2017
  12. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

    Christina Siesing, Halfdan Sorbye, Anca Dragomir, Per Pfeiffer, Camilla Qvortrup, Fredrik Pontén, Karin Jirström, Bengt Glimelius & Jakob Eberhard, 2017, In: PLoS ONE. 12, 8, e0182512.

    Research output: Contribution to journalArticle

  13. 2016
  14. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer

    Jonna Berntsson, Björn Nodin, Jakob Eberhard, Patrick Micke & Karin Jirström, 2016 Sep 1, In: International Journal of Cancer. 139, 5, p. 1129-39 11 p.

    Research output: Contribution to journalArticle

  15. 2015
  16. 2014
  17. Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.

    Sigrid Isaksson, Jakob Eberhard, Olof Ståhl, Eva Cavallin-Ståhl, G Cohn-Cedermark, S Arver, Yvonne Giwercman & Aleksander Giwercman, 2014, In: Andrology. 2, 2, p. 252-258

    Research output: Contribution to journalArticle

  18. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis

    Richard Fristedt, Jacob Elebro, Alexander Gaber, Liv Ben Dror, Margareta Heby, Yulyana Yudina, Björn Nodin, Mathias Uhlén, Jakob Eberhard & Karin Jirström, 2014, In: PLoS ONE. 9, 11, p. e112728 e112728.

    Research output: Contribution to journalArticle

  19. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.

    Charlotta Hedner, Alexander Gaber, Dejan Korkocic, Björn Nodin, Mathias Uhlén, Eugenia Kuteeva, Henrik Johannesson, Karin Jirström & Jakob Eberhard, 2014, In: Virchows Archiv: an international journal of pathology. 465, 6, p. 649-659

    Research output: Contribution to journalArticle

  20. 2013
  21. Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer.

    Leon Brokken, Yvonne Lundberg-Giwercman, Ewa Rajpert-De Meyts, Jakob Eberhard, Olof Ståhl, Gabriella Cohn-Cedermark, Gedske Daugaard, Stefan Arver & Aleksander Giwercman, 2013, In: Frontiers in Endocrinology. 4, Feb.,14, 4.

    Research output: Contribution to journalArticle

  22. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

    Karolina Boman, Anna H Larsson, U Segersten, E Kuteeva, Henrik Johannesson, Björn Nodin, Jakob Eberhard, M Uhlén, P-U Malmström & Karin Jirström, 2013, In: British Journal of Cancer. 108, 11, p. 2321-2328

    Research output: Contribution to journalArticle

Previous 1 2 Next